High-Density Lipoprotein Signaling via Sphingosine-1-Phosphate Receptors Safeguards Spontaneously Hypertensive Rats against Myocardial Ischemia/Reperfusion Injury
Open Access
- 3 April 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (4) , 497
Abstract
Background: High-density lipoprotein (HDL) protects against ischemia/reperfusion (I/R) injury via signaling through scavenger-receptor class B type-I (SR-BI) and sphingosine-1-phosphate receptors (S1PRs). We recently reported that HDL protects the hearts of spontaneously hypertensive rats (SHRs) against I/R injury in an SR-BI-dependent manner. Objective: In this study, we examined the role of S1PRs in HDL-induced protection against myocardial I/R injury in hypertensive rats. Methods: Hearts from Wistar Kyoto rats (WKYs) and SHRs were subjected to I/R injury using a modified Langendorff system. The hearts were treated with or without HDL in the presence or absence of a receptor- or kinase-specific antagonist. Cardiac hemodynamics and infarct size were measured. Target proteins were analyzed by immunoblotting and ELISA, and nitrite levels were measured using Greis reagent. Results: HDL protected the hearts of WKYs and SHRs against I/R injury. HDL, however, was more protective in WKYs. HDL protection in SHRs required lipid uptake via SR-BI and S1PR1 and S1PR3 but not S1PR2. The hearts from SHRs expressed significantly lower levels of S1PR3 than the hearts from WKYs. HDL differentially activated mediators of the SAFE and RISK pathways in WKYs and SHRs and resulted in nitric oxide generation. Blockage of these pathways abrogated HDL effects. Conclusions: HDL protects against myocardial I/R injury in normotensive and hypertensive rats, albeit to varying degrees. HDL protection in hearts from hypertensive rodents involved SR-BI-mediated lipid uptake coupled with signaling through S1PR1 and S1PR3. The extent of HDL-induced cardiac protection is directly proportional to S1PR3 expression levels. Mechanistically, the safeguarding effects of HDL involved activation of the SAFE and RISK pathways and the generation of nitric oxide.Keywords
Funding Information
- Kuwait Foundation for the Advancement of Sciences (P116-13MM-05)
This publication has 50 references indexed in Scilit:
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Downregulation of Soluble Guanylyl Cyclase in Young and Aging Spontaneously Hypertensive RatsCirculation Research, 1999
- Higher level of plasma nitric oxide in spontaneously hypertensive ratsAmerican Journal of Hypertension, 1999
- Resident Cardiac Mast Cells Degranulate and Release Preformed TNF-α, Initiating the Cytokine Cascade in Experimental Canine Myocardial Ischemia/ReperfusionCirculation, 1998
- Plasma and lipoprotein lipid composition and hepatic antioxidant status in spontaneously hypertensive (SHR) and normotensive (WKY) rats.1998
- Evidence for N‐acetylcysteine‐sensitive nitric oxide storage as dinitrosyl‐iron complexes in lipopolysaccharide‐treated rat aortaBritish Journal of Pharmacology, 1996
- Increased Activity of Constitutive Nitric Oxide Synthase in Cardiac Endothelium in Spontaneous HypertensionCirculation, 1995
- High-density lipoprotein antagonizes the inhibitory effects of oxidized low-density lipoprotein and lysolecithin on soluble guanylyl cyclaseBiochemical and Biophysical Research Communications, 1992
- Effect of Prazosin Treatment on HDL Kinetics in Patients With HypertensionAmerican Journal of Hypertension, 1990
- EFFECT OF CAPTOPRIL ON HIGH-DENSITY LIPOPROTEIN SUBFRACTIONS IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION1989